This inconsistency is likely attributable, at least in part, to the heterogeneity of the underlying hematologic malignancies requiring transplantation, the stem cell source used, donor-intrinsic characteristics, the conditioning regimens applied, KIR genotyping strategies, and the particular models used to evaluate NK alloreactivity. Here, KIR3DL1 is linked to hematologic disorder.